Cargando…

Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease

BACKGROUND: Patients with inflammatory bowel disease (IBD) are at an increased risk of developing Clostridioides difficile infection (CDI). Treatment of CDI in patients with IBD is challenging due to higher failure rates and concomitant IBD activity. OBJECTIVES: We performed a multicentre cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales: van Lingen, Emilie (E.), Baunwall, Simon (S. M. D.), Lieberknecht, Simone (S. C.), Benech, Nicolas (N.), Ianiro, Gianluca (G.), Sokol, Harry (H.), Gasbarrini, Alessandro (A.), Cammarota, Giovanni (G.), Eriksen, Marcel (M. K.), van der Meulen-de Jong, Andrea (A. E.), Terveer, Elizabeth (E. M.), Verspaget, Hein (H. W.), Vehreschild, Maria (M.), Hvas, Christian (C. L.), Keller, Josbert (J. J.)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998411/
https://www.ncbi.nlm.nih.gov/pubmed/36910163
http://dx.doi.org/10.1177/17562848231156285
_version_ 1784903458804989952
author van Lingen, Emilie (E.)
Baunwall, Simon (S. M. D.)
Lieberknecht, Simone (S. C.)
Benech, Nicolas (N.)
Ianiro, Gianluca (G.)
Sokol, Harry (H.)
Gasbarrini, Alessandro (A.)
Cammarota, Giovanni (G.)
Eriksen, Marcel (M. K.)
van der Meulen-de Jong, Andrea (A. E.)
Terveer, Elizabeth (E. M.)
Verspaget, Hein (H. W.)
Vehreschild, Maria (M.)
Hvas, Christian (C. L.)
Keller, Josbert (J. J.)
author_facet van Lingen, Emilie (E.)
Baunwall, Simon (S. M. D.)
Lieberknecht, Simone (S. C.)
Benech, Nicolas (N.)
Ianiro, Gianluca (G.)
Sokol, Harry (H.)
Gasbarrini, Alessandro (A.)
Cammarota, Giovanni (G.)
Eriksen, Marcel (M. K.)
van der Meulen-de Jong, Andrea (A. E.)
Terveer, Elizabeth (E. M.)
Verspaget, Hein (H. W.)
Vehreschild, Maria (M.)
Hvas, Christian (C. L.)
Keller, Josbert (J. J.)
author_sort van Lingen, Emilie (E.)
collection PubMed
description BACKGROUND: Patients with inflammatory bowel disease (IBD) are at an increased risk of developing Clostridioides difficile infection (CDI). Treatment of CDI in patients with IBD is challenging due to higher failure rates and concomitant IBD activity. OBJECTIVES: We performed a multicentre cohort study in patients with IBD who received fecal microbiota transplantation (FMT) for recurrent CDI (rCDI), to further investigate factors that influence the clinical outcome and course of both rCDI and IBD. DESIGN: This is a multicentre cohort study conducted in five European FMT centres. METHODS: Adult IBD patients treated with FMT for rCDI were studied. Cure was defined as clinical resolution of diarrhoea or diarrhoea with a negative C. difficile test. The definition of an IBD flare was record based. Long-term follow-up data were collected including new episodes of CDI, IBD flares, infections, hospital admissions, and death. RESULTS: In total, 113 IBD patients underwent FMT because of rCDI. Mean age of the patients was 48 years; 64% had ulcerative colitis. Concomitant rCDI was associated with an IBD flare in 54%, of whom 63% had received IBD remission-induction therapy prior to FMT. All FMT procedures were preceded by vancomycin treatment, 40% of patients received FMT via colonoscopy. CDI cure rate was 71%. Long-term follow-up data were available in 90 patients with a median follow-up of 784 days (402–1251). IBD activity decreased in 39% of patients who had active IBD at baseline, whereas an IBD flare occurred in only 5%. During follow-up of up to 2 years, 27% of the patients had infections, 39% were hospitalized, 5% underwent colectomy, and 10% died (median age of these latter patients: 72 years). CONCLUSION: FMT for rCDI in IBD patients is safe and effective, and IBD exacerbation after FMT is infrequent. Further studies should investigate the effects on IBD course following FMT.
format Online
Article
Text
id pubmed-9998411
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-99984112023-03-11 Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease van Lingen, Emilie (E.) Baunwall, Simon (S. M. D.) Lieberknecht, Simone (S. C.) Benech, Nicolas (N.) Ianiro, Gianluca (G.) Sokol, Harry (H.) Gasbarrini, Alessandro (A.) Cammarota, Giovanni (G.) Eriksen, Marcel (M. K.) van der Meulen-de Jong, Andrea (A. E.) Terveer, Elizabeth (E. M.) Verspaget, Hein (H. W.) Vehreschild, Maria (M.) Hvas, Christian (C. L.) Keller, Josbert (J. J.) Therap Adv Gastroenterol Clostridioides difficile Infection: Approaching a Difficult Menace BACKGROUND: Patients with inflammatory bowel disease (IBD) are at an increased risk of developing Clostridioides difficile infection (CDI). Treatment of CDI in patients with IBD is challenging due to higher failure rates and concomitant IBD activity. OBJECTIVES: We performed a multicentre cohort study in patients with IBD who received fecal microbiota transplantation (FMT) for recurrent CDI (rCDI), to further investigate factors that influence the clinical outcome and course of both rCDI and IBD. DESIGN: This is a multicentre cohort study conducted in five European FMT centres. METHODS: Adult IBD patients treated with FMT for rCDI were studied. Cure was defined as clinical resolution of diarrhoea or diarrhoea with a negative C. difficile test. The definition of an IBD flare was record based. Long-term follow-up data were collected including new episodes of CDI, IBD flares, infections, hospital admissions, and death. RESULTS: In total, 113 IBD patients underwent FMT because of rCDI. Mean age of the patients was 48 years; 64% had ulcerative colitis. Concomitant rCDI was associated with an IBD flare in 54%, of whom 63% had received IBD remission-induction therapy prior to FMT. All FMT procedures were preceded by vancomycin treatment, 40% of patients received FMT via colonoscopy. CDI cure rate was 71%. Long-term follow-up data were available in 90 patients with a median follow-up of 784 days (402–1251). IBD activity decreased in 39% of patients who had active IBD at baseline, whereas an IBD flare occurred in only 5%. During follow-up of up to 2 years, 27% of the patients had infections, 39% were hospitalized, 5% underwent colectomy, and 10% died (median age of these latter patients: 72 years). CONCLUSION: FMT for rCDI in IBD patients is safe and effective, and IBD exacerbation after FMT is infrequent. Further studies should investigate the effects on IBD course following FMT. SAGE Publications 2023-03-08 /pmc/articles/PMC9998411/ /pubmed/36910163 http://dx.doi.org/10.1177/17562848231156285 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Clostridioides difficile Infection: Approaching a Difficult Menace
van Lingen, Emilie (E.)
Baunwall, Simon (S. M. D.)
Lieberknecht, Simone (S. C.)
Benech, Nicolas (N.)
Ianiro, Gianluca (G.)
Sokol, Harry (H.)
Gasbarrini, Alessandro (A.)
Cammarota, Giovanni (G.)
Eriksen, Marcel (M. K.)
van der Meulen-de Jong, Andrea (A. E.)
Terveer, Elizabeth (E. M.)
Verspaget, Hein (H. W.)
Vehreschild, Maria (M.)
Hvas, Christian (C. L.)
Keller, Josbert (J. J.)
Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
title Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
title_full Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
title_fullStr Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
title_full_unstemmed Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
title_short Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
title_sort short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent clostridioides difficile infection in patients with inflammatory bowel disease
topic Clostridioides difficile Infection: Approaching a Difficult Menace
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998411/
https://www.ncbi.nlm.nih.gov/pubmed/36910163
http://dx.doi.org/10.1177/17562848231156285
work_keys_str_mv AT vanlingenemiliee shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT baunwallsimonsmd shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT lieberknechtsimonesc shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT benechnicolasn shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT ianirogianlucag shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT sokolharryh shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT gasbarrinialessandroa shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT cammarotagiovannig shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT eriksenmarcelmk shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT vandermeulendejongandreaae shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT terveerelizabethem shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT verspagetheinhw shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT vehreschildmariam shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT hvaschristiancl shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease
AT kellerjosbertjj shortandlongtermfollowupafterfecalmicrobiotatransplantationastreatmentforrecurrentclostridioidesdifficileinfectioninpatientswithinflammatoryboweldisease